Amyloidosis is a protein misfolding disorder characterized by the extracellular deposition of insoluble amyloid fibrils, derived from abnormally folded proteins. These fibrils disrupt tissue structure and function, leading to organ dysfunction. The condition encompasses various subtypes, each associated with distinct precursor proteins and clinical manifestations. 99mTc-PYP scintigraphy is used widely and holds significant importance for diagnosis. 68Ga-FAPI is also a promising radiotracer for various diseases. To our knowledge, this is the first case of a patient with hereditary transthyretin amyloidosis with cardiac involvement, which FAPI PET showed diffuse increased myocardial uptake.
23 February 2024 in Molecular Imaging and Radionuclide Therapy
We present the case of a 58-year-old man with advanced medullary thyroid carcinoma who had a treatment history with different types of modalities. In the follow-up, the patient had rising calcitonin and CEA levels. Metastatic lymph nodes, liver, and bone metastases with varying degrees of uptake were detected on 18F-fluorodeoxyglucose (FDG) and 68Ga-DOTATATE positron emission tomography/computed tomography (PET/CT). 68Ga prostate-specific membrane antigen (PSMA) PET/CT was performed to explore whether the patient might have a chance for PSMA-targeted radionuclide therapy, and increased PSMA expression was noted in most of the metastatic lesions, even some of which have higher PSMA uptake than 18F-FDG and 68Ga-DOTATATE.
Objectives: Radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) is associated with challenges in both imaging and treatment due to resistance to I-131. The aim of this study is to compare the lesion detection rates of [18F] fluorodeoxyglucose (FDG) PET/computed tomography [CT] and [68Ga]Ga-prostate specific membrane antigen (PSMA)-11 PET/CT, and to investigate the theranostic potential of PSMA in RAIR-DTC. Methods: Thirty-eight RAIR-DTC patients followed between 2022 and 2024 underwent [18F]FDG PET/CT and [68Ga]Ga-PSMA-11 PET/CT. Lesions with uptake exceeding background activity were considered positive, while physiological uptake areas and benign-appearing foci were excluded. Lesion maximum standardized uptake value (SUVmax), tumor-to-background ratio (TBR), and detection rates were calculated and compared. Results: [18F]FDG PET/CT detected more lesions overall than [68Ga]Ga-PSMA-11 PET/CT (96.8 vs. 60.1%), particularly in the thyroid bed, lymph nodes, and lungs. However, both modalities identified the same number of bone lesions. While [18F]FDG PET/CT was superior in most patients, [68Ga]Ga-PSMA-11 PET/CT detected more lesions in a subset of patients and performed better in the pure classic papillary thyroid carcinoma subtype compared to other subtypes (71.7 vs. 50.3%). SUVmax and TBR values were higher on [18F]FDG PET/CT, yet in 14 patients (36.8%), [68Ga]Ga-PSMA-11 PET/CT identified lesions with SUVmax exceeding liver SUVmax, indicating potential eligibility for PSMA-based radionuclide therapy. Conclusion: Although [18F]FDG PET/CT demonstrated superior overall lesion detection, [68Ga]Ga-PSMA-11 PET/CT identified more lesions in a subset of patients. [68Ga]Ga-PSMA-11 PET/CT appears to be more beneficial in the pure classic subtype compared to other histological variants. Notably, [68Ga]Ga-PSMA-11 PET/CT demonstrated high uptake in a considerable number of patients and may provide theranostic value in RAIR-DTC patients with limited treatment options.
2 February 2022 in Molecular Imaging and Radionuclide Therapy
Behcet's syndrome (BS) is a variable vessel vasculitis with multi-organ involvement. Recurrent episodes of oral and genital ulcers, papulopustular and erythema nodosum-like skin lesions, and arthritis are relatively more frequent, whereas uveitis, venous and arterial lesions, nervous system, and gastrointestinal involvement are less common, but are severe manifestations. The frequency of gastrointestinal involvement shows important variation between countries as more common in the Far East and the United States, and much less common in Turkey and the Middle East. The main clinical signs of gastrointestinal Behcet's disease include abdominal pain, diarrhea, blood in the stool, fever, and weight loss. Ulcers seen in the terminal ileum, cecum, and ascending colon are common endoscopic findings. Herein, we presented the positron emission tomography/magnetic resonance imaging findings of gastrointestinal involvement in BS.
1 June 2023 in Molecular Imaging and Radionuclide Therapy
Ovarian cancer is one of the deadliest tumors among women. It mostly metastasizes to the liver, pleura, lungs, and bones. We present a sixty-six -year-old patient with skin lesions. The patient who underwent biopsy due to skin lesions was diagnosed with ovarian cancer.18F-fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance imaging (PET/MRI) performed for metastasis search shows widespread skin involvement, especially in the lower abdomen and legs. Skin involvement it ovarian cancer can be rarely seen, and in this article we would like to share 18F-FDG PET/MRI of skin involvement in ovarian cancer.